Alethiomics
Alethiomics is a pre-clinical biotech company leveraging the power of single cell multi-omic analysis to identify novel drug targets and uncover new biology to design better treatments for patients with blood cancer.
- What
- Life Sciences
- When
- Dec 2021
- CEO
- Mark Throsby
- Status
- Private
- Investment
- Active
- OSE Board Director
- Sally Dewhurst